［1］ Ducharme S, Dols A, Laforce R, et al. Recommendations to distinguish behavioural variant frontotemporal dementia from psychiatric disorders［J］. Brain, 2020, 143(6): 1632－1650.
［2］ Naasan G, Shdo S M, Rodriguez E M, et al. Psychosis in neurodegenerative disease: differential patterns of hallucination and delusion symptoms［J］. Brain, 2021, 144(3): 999－1012.
［3］ Pressman P S, Matlock D, Ducharme S. Distinguishing behavioral variant frontotemporal dementia from primary psychiatric disorders: a review of recently published consensus recommendations from the neuropsychiatric international consortium for frontotemporal dementia［J］. J Neuropsychiatry Clin Neurosci, 2021, 33(2): 152－156.
［4］ O'Connor C M, Ahmed S, Devenney E, et al. Diagnostic delays and misdiagnosis in frontotemporal dementia: a multicenter cohort study［J］. Neurology, 2021, 97(8): e789－e801.
［5］ Boeve B F, Boxer A L, Kumfor F, et al. Advances and controversies in frontotemporal dementia: diagnosis, biomarkers, and therapeutic considerations［J］. Lancet Neurol, 2022, 21(3): 258－272.
［6］ 中华医学会老年医学分会老年神经病学组. 额颞叶变性专家共识撰写组.额颞叶变性诊治中国专家共识［J］. 中华老年医学杂志, 2022, 41(8): 893－907.
［7］ Hofmann A, Häsler L M, Lambert M, et al. Comparative neurofilament light chain trajectories in CSF and plasma in autosomal dominant Alzheimer's disease［J］. Nat Commun, 2024, 15(1): 9982.
［8］ 李秋璇, 于欣, 李汇子, 等. 行为变异型额颞叶痴呆早期主要临床特点及相关影像学特征研究［J］. 临床精神医学杂志, 2022, 32(5): 412－414.
［9］ Ghetti B, Buratti E, Boeve B, et al. Frontotemporal dementias emerging milestones of the 21st century: advances in experimental medicine and biology1281［M］. Cham: Springer, 2021: 1－11.
［10］ Bartochowski Z, Gatla S, Khoury R, et al. Empathy changes in neurocognitive disorders: a review［J］. Ann Clin Psychiatry, 2018, 30(3): 220－232.
［11］ Castro-Suarez S, Guevara-Silva E, Caparó-Zamalloa C, et al. Knowledge and attitudes for the management of behavioral variant of frontotemporal dementia［J］. Front Neurol, 2022, 12: 786448.
［12］ Ahmed R M, Tse N Y, Chen Y, et al. Neural correlates of fat preference in frontotemporal dementia: translating insights from the obesity literature［J］. Ann Clin Transl Neurol, 2021, 8(6): 1318－1329.
［13］ Pytel V, Hernández-Lorenzo L, Torre-Fuentes L, et al. Whole-exome sequencing and C9orf72 analysis in primary progressive aphasia［J］. J Alzheimers Dis, 2021, 80(3): 985－990.
［14］ Tan Y J, Yong A C W, Foo J N, et al. C9orf72 expansions are the most common cause of genetic frontotemporal dementia in a Southeast Asian cohort［J］. Ann Clin Transl Neurol, 2023, 10(4): 568－578.
［15］ Gaetani L, Blennow K, Calabresi P, et al. Neurofilament light chain as a biomarker in neurological disorders［J］. J Neurol Neurosurg Psychiatry, 2019, 90(8): 870－881.
［16］ 马冰冰, 王凯华. 血清神经丝轻链蛋白在中枢神经系统疾病中的研究进展［J］. 中国实用神经疾病杂志, 2021, 24(21): 1916－1923.
［17］ Katisko K, Cajanus A, Korhonen T, et al. Prodromal and early bvFTD: evaluating clinical features and current biomarkers［J］. Front Neurosci, 2019, 13: 658.
［18］ Bavato F, Barro C, Schnider L K, et al. Introducing neurofilament light chain measure in psychiatry: current evidence, opportunities, and pitfalls［J］. Mol Psychiatry, 2024, 29(8): 2543－2559.
［19］ Heuer H W, Whitwell J L, Schwarz J, et al. Association of CSF neurofilament light chain with clinical progression in frontotemporal dementia［J］. Neurology, 2023, 100(24): e2495－e2506.
［20］ Palmqvist S, Whitson H E, Allen L A, et al. Alzheimer's association clinical practice guideline on the use of blood-based biomarkers in the diagnostic workup of suspected Alzheimer's disease within specialized care settings［J］. Alzheimers Dement, 2025, 21(7): e70535.
［21］ 国家卫生健康委能力建设和继续教育中心, 中国神经科学学会, 衰老标志物联合体, 等. 阿尔茨海默病体液标志物临床应用中国指南(2024版)［J］. 中华医学杂志, 2024, 104(35): 3292－3306.
［22］ McShane R, Westby M J, Roberts E, et al. Memantine for dementia［J］. Cochrane Database Syst Rev, 2019, 3(3): CD003154.
［23］ Neylan K D, Miller B L. New approaches to the treatment of frontotemporal dementia［J］. Neurotherapeutics, 2023, 20(4): 1055－1065.
［24］ 杨霞, 纪勇. 行为变异型额颞叶痴呆的临床研究进展［J］. 阿尔茨海默病及相关病, 2023, 6(3): 249－252.
［25］ Nan H T, Kim Y J, Chu M, et al. Genetic and clinical landscape of Chinese frontotemporal dementia: dominance of TBK1 and OPTN mutations［J］. Alzheimers Res Ther, 2024, 16(1): 127.
［26］ Aghdam M R F, Vodovnik A, Hameed R A. Role of telemedicine in multidisciplinary team meetings［J］. J Pathol Inform, 2019, 10: 35.
［27］ Sejourne C, Barker M S, Heath M R, et al. Neuropsychiatric and behavioral symptom clusters in frontotemporal dementia［J］.J Alzheimers Dis Rep, 2025, 9: 25424823251324391.
［28］ 杨静,郑东明, 曹迪. 健康信念模式护理对阿尔茨海默病患者生活质量的影响［J］. 中国医科大学学报, 2019, 48(6): 570－573.
［29］ 万真真,苗晓慧, 张红菊. 痴呆患者精神行为症状群的可改变因素研究［J/OL］. 空军军医大学学报, 1-14(2024-12-09)［2025-09-18］. https://link.cnki.net/urlid/61.1526.R.20241206.1545.012.
|
